Introduction
The temporomandibular joint (TMJ) is frequently affected in juvenile idiopathic arthritis (JIA). Depending on cohorts, up to 80 percent of JIA patients with peripheral arthritis have been shown to have synovitis of the TMJ on MRI [1] . It has also been found in pediatric Sjögren disease and sarcoidosis [2] , and our report is focusing on TMJ arthritis in myositis-associated pediatric rheumatologic diseases which also share peripheral ar-
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thritis as a common feature.
Juvenile dermatomyositis (JDM) is the most common chronic childhood inflammatory myopathy [3] . It primarily manifests as weakness of the proximal muscle groups, heliotrope rash, and Gottron papules, while one third of patients present with arthritis as well [4] . Mixed connective tissue disease (MCTD) is an autoimmune condition heralded by vasculopathy leading to Raynaud syndrome, myositis, erosive arthritis, and potentially multiorgan involvement.
Based on our experience with JIA, maximal interincisal opening (MIO) measurements have been part of the standard physical exam when patients present with peripheral arthritis. In addition, subjective complaints of jaw pain or objective mandibular asymmetry in any referred patient would result in MIO assessment. Considering the possible devastating outcomes of TMJ arthritis in growing children (e.g., micrognathia), further imaging assessment by MRI of the TMJ with and without intravenous contrast is pursued if the mouth opening is <40 mm, a midline incisor deviation is present on the opening, there is tenderness in the TMJ area on examination, or there is asymmetry in the appearance of the lower jaw.
An Institutional Review Board-approved retrospective review of electronic medical records at the Children' s of Alabama Rheumatology Clinic (Birmingham, Alabama) from January 2010 to March 2012 identified four JDM and three pediatric MCTD patients who had MRI-proven arthritis of the TMJ (i.e., synovial enhancement after intravenous contrast administration with or without erosions). Patients with peripheral arthritis both in JDM and MCTD showed TMJ synovitis on MRI (Figure 1) can be found in patients who present predominantly with myositis, especially in those with peripheral arthritis. Considering the lack of reliable symptoms or signs on physical examination, TMJ MRI with and without contrast is both highly sensitive in identifying affected individuals prior to radiographic findings of bony damage [5] , and highly specific [6] in identifying TMJ arthritis. In the past, masticatory abnormalities in adults with MCTD have been described [7] , and erosions on panoramic radiographs were shown in 19% (3/16). JDM patients' reduced MIO has also been reported, but rather attributed to muscle weakness [8] . To our knowledge, there is only one case of pediatric MCTD with TMJ-proven arthritis in the medical literature [9] , whereas our report is the first to document synovitis of the TMJ in children -not only with MCTD, but also with JDM.
The implications of TMJ arthritis in a child with JDM or MCTD are several-fold, just like in JIA. Joint destruction can affect facial proportions, bite and mastication. Even non-erosive TMJ arthritis with chronic pain can lead to decreased use and thus to improper bone development and remodeling during growth. As seen in JIA, TMJ arthritis can progress despite systemic therapy. Two of the seven patients in our cohort had TMJ condylar head erosions by MRI (Table 1) . Since condylar resorption can lead to mandibular asymmetry and subsequently to facial deformity, based on data from JIA cohorts, intraarticular steroid injection might be suggested [10] . In JDM, concomitant systemic therapy with high-dose steroids could possibly effect TMJ disease progression, but MCTD patients are well known to have erosive peripheral arthritis despite aggressive therapy and therefore might benefit from intraarticular TMJ steroid injection, just like in JIA. Future clinical trials will likely be helpful in addressing the proper management.
In summary, TMJ arthritis is under-recognized, not only in JIA, but also likely in JDM and in pediatric MCTD. The latter patients with peripheral arthritis and/or decreased MIO, with or without deviation on the mouth opening, should undergo contrast-enhanced TMJ MRI evaluation to assess arthritis. The use of long-acting intraarticular corticosteroid injection could be considered when there is TMJ disease progression despite systemic therapy.
